🇺🇸
United States · US · US:62032-915_d5a6773d-ca09-4b9a-8cbb-4611d29fb7a7
Obagi-C C-Rx System Normal-Oily Skin Intervention
SPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerObagi Cosmeceuticals LLC
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1162032915011 KIT in 1 KIT (62032-915-01) * 177 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 30 mL in 1 BOTTLE, GLASS (62032-122-10) * 1 TUBE in 1 CARTON (62032-140-09) / 85 g in 1 TUBE * 57 g in 1 BOTTLE, PLASTIC (62032-105-36)
Annotations
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"route": null,
"spl_meta": {
"321e58d0-9964-4da9-af6b-66ba81b60cf7": {
"match": "brand_token",
"title": "OBAGI-C FX SYSTEM NORMAL-OILY SKIN BRIGHTENING SYSTEM WITH ARBUTIN (HOMOSALATE, OCTISALATE, ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC]",
"spl_version": "3",
"published_date": "2026-01-28"
}
},
"productid": "62032-915_d5a6773d-ca09-4b9a-8cbb-4611d29fb7a7",
"productndc": "62032-915",
"dosage_form": "KIT",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": null,
"proprietary_name": "Obagi-C C-Rx System Normal-Oily Skin Intervention",
"active_ingred_unit": null,
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER",
"nonproprietary_name": "HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE",
"start_marketing_date": "20191202",
"active_numerator_strength": null
}Access this data programmatically
Query Obagi-C C-Rx System Normal-Oily Skin Intervention and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.